Cases 21 - 30 of 2,058
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al
as 1:2023cv01372
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff:
AbbVie Inc.
Defendant:
Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22452
Plaintiff:
BOBBY WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GREENE v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22298
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
NATHANIEL GREENE
Defendant:
AUROBINDO PHARMA, LTD., SCIEGEN PHARMACEUTICALS, INC., U.S., WESTMINSTER PHARMACEUTICALS and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MCNALL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv21327
Plaintiff:
MARK MCNALL
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2023cv01193
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Counter Claimant:
Eugia Pharma Specialities Ltd.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv01182
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
IVERS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv21150
Plaintiff:
ANTHONY IVERS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al
as 2:2023cv20354
Plaintiff:
AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant:
ALKEM LABORATORIES LTD., AUROBINDO PHARMA USA, INC., HETERO USA INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Louisiana Health Service & Indemnity Company et al v. Celgene Corporation et al
as 1:2023cv07871
Plaintiff:
Louisiana Health Service & Indemnity Company individually and on behalf of all others similarly situated doing business as Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc.
Defendant:
Celgene Corporation, Bristol Myers Squibb Company, Aurobindo Pharma Limited and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
